{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:12:18Z","timestamp":1788426738724,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["LSHC-CT-2006-018702"],"award-info":[{"award-number":["LSHC-CT-2006-018702"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2017_SGR_1134"],"award-info":[{"award-number":["2017_SGR_1134"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["GCB15152978SOEN"],"award-info":[{"award-number":["GCB15152978SOEN"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["18\/00419"],"award-info":[{"award-number":["18\/00419"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["22\/01467"],"award-info":[{"award-number":["22\/01467"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["HORIZON-MISS-2021-CANCER-02"],"award-info":[{"award-number":["HORIZON-MISS-2021-CANCER-02"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","award":["101096667"],"award-info":[{"award-number":["101096667"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ad.2026.104648","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:24:33Z","timestamp":1776144273000},"page":"104648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complete Lymph Node Dissection vs Observation in Patients With Cutaneous Melanoma and Positive Sentinel Lymph Node Biopsy With High-risk Criteria: Multicenter Analysis in Hospitals in the Mediterranean Area"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5769-0502","authenticated-orcid":false,"given":"E.","family":"Samaniego-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Podlipnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ribero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Nagore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Boada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ca\u00f1ueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Paradela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"de Unamuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rodr\u00edguez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Roccuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Requena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Manrique-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Richarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ruiz-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Traves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Espa\u00f1a-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Botella-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Gonz\u00e1lez-Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Descalzo-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tejera-Vaquerizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2026.104648_bib0260","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2026.104648_bib0265","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0270","unstructured":"Cutaneous M: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) NCCN.org NCCN Guidelines for Patients\u00ae available at www.nccn.org\/patients. 2024."},{"key":"10.1016\/j.ad.2026.104648_bib0275","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jso.26302","article-title":"Surgeon decision-making for management of positive sentinel lymph nodes in the post-Multicenter Selective Lymphadenectomy Trial II era: a survey study","volume":"123","author":"Hui","year":"2021","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0280","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bjps.2021.09.077","article-title":"Melanoma sentinel lymph node biopsy and completion lymph node dissection: a regional hospital experience","volume":"75","author":"Williams","year":"2022","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.ad.2026.104648_bib0285","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4081\/oncol.2019.433","article-title":"Evolving management of positive regional lymph nodes in melanoma: Past, present and future directions","volume":"13","author":"Fayne","year":"2019","journal-title":"Oncol Rev."},{"key":"10.1016\/j.ad.2026.104648_bib0290","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11864-018-0575-4","article-title":"Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma","volume":"19","author":"Masoud","year":"2018","journal-title":"Curr Treat Options Oncol."},{"key":"10.1016\/j.ad.2026.104648_bib0295","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1245\/s10434-017-6267-7","article-title":"Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice guideline update","volume":"25","author":"Wong","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0300","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1245\/s10434-008-9885-2","article-title":"Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0305","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3747\/co.26.5123","article-title":"Melanoma nodal management in Ontario the year after the 2012 American Society of Clinical Oncology and Society of Surgical Oncology guideline","volume":"26","author":"Latosinsky","year":"2019","journal-title":"Curr Oncol."},{"key":"10.1016\/j.ad.2026.104648_bib0310","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jso.25160","article-title":"National practice patterns of completion lymph node dissection for sentinel node-positive melanoma","volume":"118","author":"Hewitt","year":"2018","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0315","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.suronc.2017.08.006","article-title":"Practice variation in Sentinel Lymph Node Biopsy for melanoma patients in different geographical regions in the Netherlands","volume":"26","author":"Verstijnen","year":"2017","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0320","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1245\/s10434-019-07204-2","article-title":"Trends in sentinel lymph node biopsy enactment for cutaneous melanoma","volume":"26","author":"El Sharouni","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0325","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.surg.2021.12.025","article-title":"Evidence and implementation gaps in management of sentinel node-positive melanoma in the United States","volume":"172","author":"Broman","year":"2022","journal-title":"Surgery."},{"key":"10.1016\/j.ad.2026.104648_bib0330","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1002\/cam4.2358","article-title":"Survival analysis and sentinel lymph node status in thin cutaneous melanoma: a multicenter observational study","volume":"8","author":"Tejera-Vaquerizo","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ad.2026.104648_bib0335","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.ad.2026.104648_bib0340","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0345","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1111\/jdv.14485","article-title":"\u00bfIs mitotic rate still useful in the management of patients with thin melanoma?","volume":"31","author":"Tejera-Vaquerizo","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2026.104648_bib0350","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00008390-200506000-00005","article-title":"Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis","volume":"15","author":"Nagore","year":"2005","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ad.2026.104648_bib0355","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1200\/JCO.2010.31.6760","article-title":"Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and dewar topography criteria","volume":"29","author":"Van Der Ploeg","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0360","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ad.2024.07.017","article-title":"An\u00e1lisis multic\u00e9ntrico del manejo quir\u00fargico y tratamiento adyuvante de los pacientes con melanoma y positividad en la biopsia selectiva del ganglio centinela","volume":"116","author":"Samaniego-Gonz\u00e1lez","year":"2025","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2026.104648_bib0365","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1056\/NEJMe1704290","article-title":"The enigma of regional lymph nodes in melanoma","volume":"376","author":"Coit","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2026.104648_bib0370","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jamcollsurg.2020.11.014","article-title":"Surveillance of sentinel node-positive melanoma patients with reasons for exclusion from MSLT-II: multi-institutional propensity score matched analysis","volume":"232","author":"Broman","year":"2021","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ad.2026.104648_bib0375","first-page":"457","article-title":"When is it worth performing lymphadenectomy in patients with melanoma micrometastases? A 20-year experience retrospective analysis","volume":"89","author":"Avil\u00e9s-Izquierdo","year":"2021","journal-title":"Cir Cir (Engl Ed)"},{"key":"10.1016\/j.ad.2026.104648_bib0380","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/mmt-2016-0023","article-title":"Lymph node dissection for melanoma: where do we stand?","volume":"4","author":"Neuwirth","year":"2017","journal-title":"Melanoma Manag"},{"key":"10.1016\/j.ad.2026.104648_bib0385","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1416685","article-title":"Implications of tumor-positive sentinel lymph nodes in single vs multiple nodal basins in melanoma","volume":"14","author":"Reyes","year":"2024","journal-title":"Front Oncol."},{"key":"10.1016\/j.ad.2026.104648_bib0390","first-page":"279","article-title":"Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires","volume":"84","author":"Nardi","year":"2024","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.ad.2026.104648_bib0395","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1245\/s10434-021-09804-3","article-title":"Nodal recurrence is a primary driver of early relapse for patients with sentinel lymph node-positive melanoma in the modern therapeutic era","volume":"28","author":"Mitra","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0400","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1245\/s10434-022-12345-y","article-title":"Predicting regional lymph node recurrence in the modern age of tumor-positive sentinel node melanoma: the role of the first postoperative ultrasound","volume":"29","author":"Keller","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0405","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care","volume":"18","author":"Keung","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ad.2026.104648_bib0410","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ad.2026.104648_bib0415","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","article-title":"Melanoma staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond","volume":"25","author":"Gershenwald","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0420","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/PAS.0000000000002269","article-title":"Stage III Melanoma: A Proposed Staging Model That Outperforms the American Joint Committee on Cancer Eighth Edition Staging System","volume":"48","author":"Balaban","year":"2024","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.ad.2026.104648_bib0425","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2020.04.022","article-title":"The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node-positive melanoma without the need for completion lymph node dissection","volume":"134","author":"Verver","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ad.2026.104648_bib0430","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10434-001-0109-2","article-title":"Risk factors for nodal recurrence after lymphadenectomy for melanoma","volume":"8","author":"Pidhorecky","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0435","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.ejca.2014.02.010","article-title":"Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomy","volume":"50","author":"Khosrotehrani","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ad.2026.104648_bib0440","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1245\/s10434-008-0024-x","article-title":"Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?","volume":"15","author":"Frankel","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0445","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/PAS.0b013e31826d25f9","article-title":"The distribution of microscopic melanoma metastases in sentinel lymph nodes","volume":"36","author":"Lobo","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2026.104648_bib0450","first-page":"1165","article-title":"Survival in patients with sentinel node-positive melanoma with extranodal extension","volume":"19","author":"Maurichi","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ad.2026.104648_bib0455","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/annonc\/mdx176","article-title":"Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E\/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study","volume":"28","author":"Long","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0460","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1001\/jamaoncol.2018.2668","article-title":"Modeled prognostic subgroups for survival and treatment outcomes in BRAF V600-mutated metastatic melanoma: pooled analysis of 4 randomized clinical trials","volume":"4","author":"Hauschild","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0465","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1080\/0284186X.2019.1620966","article-title":"Real-world data on PD-1 inhibitor therapy in metastatic melanoma","volume":"58","author":"Arheden","year":"2019","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.ad.2026.104648_bib0470","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/oncolo\/oyad073","article-title":"Development and validation of a prognostic risk model for patients with advanced melanoma treated with immune checkpoint inhibitors","volume":"28","author":"Stukalin","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.ad.2026.104648_bib0475","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12672-022-00538-6","article-title":"Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis","volume":"13","author":"Qin","year":"2022","journal-title":"Discov Oncol."},{"key":"10.1016\/j.ad.2026.104648_bib0480","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ijd.17379","article-title":"Predictors of survival in immunotherapy-based treatments in advanced melanoma: a meta-analysis","volume":"64","author":"Li","year":"2025","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.ad.2026.104648_bib0485","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S1470-2045(15)70122-1","article-title":"Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial","volume":"16","author":"Eggermont","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0490","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2026.104648_bib0495","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S1470-2045(20)30494-0","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage IIIB\u2013C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial","volume":"21","author":"Ascierto","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ad.2026.104648_bib0500","first-page":"589","article-title":"Tumor mitotic rate is an independent predictor of survival for nonmetastatic melanoma","volume":"164","author":"Evans","year":"2018","journal-title":"Surgery (United States)"},{"key":"10.1016\/j.ad.2026.104648_bib0505","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.amjsurg.2010.07.037","article-title":"Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma?","volume":"200","author":"Roach","year":"2010","journal-title":"Am J Surg"},{"key":"10.1016\/j.ad.2026.104648_bib0510","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1245\/s10434-014-4349-3","article-title":"Tumor mitotic rate added to the equation: melanoma prognostic factors changed? A single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients","volume":"22","author":"Speijers","year":"2015","journal-title":"Ann Surg Oncol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000173102600058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000173102600058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:14:41Z","timestamp":1788423281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000173102600058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S000173102600058X"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2026.104648","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete Lymph Node Dissection vs Observation in Patients With Cutaneous Melanoma and Positive Sentinel Lymph Node Biopsy With High-risk Criteria: Multicenter Analysis in Hospitals in the Mediterranean Area","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2026.104648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"104648"}}